In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

OpenAI is expanding its efforts to contain emerging risks posed by artificial intelligence, backing a new biotech spinoff aimed at stopping malicious actors from using advanced models to create ...

Artificial intelligence (AI) for science has rapidly gained momentum at an extreme pace. Models trained on the scientific record are generating hypotheses and even running experiments in automated ...

By Deepa Seetharaman SAN FRANCISCO -ChatGPT maker OpenAI on Thursday said it will invest in a startup focused on blocking bad ...

Existing frameworks for explainable artificial intelligence (XAI) and AI governance, such as the EU AI Act and the NIST AI ...

NEW YORK, NY / ACCESS Newswire / November 7, 2025 / New to The Street, one of America’s leading business television and multi ...

Have you ever wondered how scientists test new medicines before they reach people? The process must be safe, accurate, and ...